{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:23:46Z","timestamp":1783142626121,"version":"3.54.6"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00365","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:08:29Z","timestamp":1589533709000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["TuberOus SClerosis Registry to Increase Disease Awareness: A Review on Alignment of Its Planning, Execution, and Publications With European Medicines Agency Guidelines"],"prefix":"10.3389","volume":"11","author":[{"given":"Ruben","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Thole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 G.","family":"Ruiz de Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.5272\/jimab.2016222.1166","article-title":"Patient registries for rare diseases","volume":"22","author":"Deliverska","year":"2016","journal-title":"J IMAB"},{"key":"B2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13023-018-0836-0","article-title":"Rare disease registries: potential applications towards impact on development of new drug treatments","volume":"13","author":"Jansen-van der Weide","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B3","volume-title":"Registries for Evaluating Patient Outcomes: A User's Guide","author":"Gliklich","year":"2014"},{"key":"B4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jval.2016.02.007","article-title":"Balancing the optimal and the feasible: a practical guide for setting up patient registries for the collection of real-world data for health care decision making based on Dutch experiences","volume":"20","author":"de Groot","year":"2017","journal-title":"Val Health"},{"key":"B5","first-page":"7","article-title":"Council recommendation of 8 june 2009 on an action in the field of rare diseases (2009\/C 151\/02)","year":"2009","journal-title":"Off J Eur Union."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3390\/ijerph15081644","article-title":"Recommendations for improving the quality of rare disease registries","volume":"15","author":"Kodra","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"B7","unstructured":"Rare Disease Registries in Europe2019"},{"key":"B8","unstructured":"EUCERD Core Recommendations on Rare Disease Patient Registration and Data Collection2013"},{"key":"B9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1750-1172-9-81","article-title":"The European cystic fibrosis society patient registry: valuable lessons learned on how to sustain a disease registry","volume":"9","author":"Viviani","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.curtheres.2018.12.001","article-title":"Pediatric drug development: challenges and opportunities","volume":"90","author":"Spadoni","year":"2019","journal-title":"Curr Ther Res Clin Exp"},{"key":"B11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000475595","article-title":"Predictors of loss to follow-up among children with type 2 diabetes","volume":"87","author":"Shoemaker","year":"2017","journal-title":"Hormone Res Paed"},{"key":"B12","unstructured":"Discussion Paper: Use of Patient Disease Registries for Regulatory Purposes- Methodological and Operational Considerations.2018"},{"key":"B13","unstructured":"Gesetz f\u00fcr mehr Sicherheit in der Arzneimittelversorgung"},{"key":"B14","unstructured":"Registry-Data \u2013 of Sufficient Quality \u2013 Are Suitable for the Extended Benefit Assessment of Drugs."},{"key":"B15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","article-title":"The tuberous sclerosis complex","volume":"1184","author":"Orlova","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13023-014-0182-9","article-title":"TOSCA-first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex","volume":"9","author":"Kingswood","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/0883073807309250","article-title":"Clinical presentation and diagnosis of tuberous sclerosis complex in infancy","volume":"23","author":"Datta","year":"2008","journal-title":"J Child Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","article-title":"TuberOus SClerosis registry to increase disease awareness (TOSCA)-baseline data on 2093 patients","volume":"12","author":"Kingswood","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3389\/fneur.2019.01182","article-title":"The TOSCA registry for tuberous sclerosis- lessons learnt for future registry development in rare and complex diseases","volume":"10","author":"Marques","year":"2019","journal-title":"Front Neurol"},{"key":"B20","unstructured":"JRC EU RD Platform Releases the Set of Common Data Elements for RD Registration"},{"key":"B21","unstructured":"Report on Cystic Fibrosis Registries - Workshop 14 June 2017 Patient Registries Initiative.2017"},{"key":"B22","unstructured":"Report on Multiple Sclerosis Registries - Workshop 7 July 2017 Patient Registries Initiative.2017"},{"key":"B23","unstructured":"Report on CAR T-cell Therapy Registries - Workshop 9 February 2018 Patient Registries Initiative.2018"},{"key":"B24","unstructured":"Report on Haemophilia Registies - Workshop 8 June 2018 Patient Registries Initiative."},{"key":"B25","volume-title":"Rare Diseases and Classifications.","year":""},{"key":"B26","unstructured":"Medical Dictionary for Regulatory Activities"},{"key":"B27","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/ndt\/gfy063","article-title":"Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease awareness (TOSCA)","volume":"34","author":"Kingswood","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fneur.2019.00705","article-title":"Clinical characteristics of subependymal giant cell astrocytoma in tuberous sclerosis complex: baseline findings from the TOSCA natural history registry","volume":"10","author":"Jansen","year":"2019","journal-title":"Front Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13023-018-0901-8","article-title":"TSC-Associated Neuropsychiatric Disorders (TAND): findings from the TOSCA natural history study","volume":"13","author":"de Vries","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/epi4.12286","article-title":"Epilepsy in tuberous sclerosis complex: findings from the TOSCA natural history study","volume":"4","author":"Nabbout","year":"2018","journal-title":"Epilepsia Open"},{"key":"B32","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3389\/fneur.2019.00821","article-title":"Newly diagnosed and growing subependymal giant cell astrocytoma in adults with tuberous sclerosis complex: evidence from the international TOSCA registry","volume":"10","author":"Jansen","year":"2019","journal-title":"Front Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3389\/fneur.2019.01144","article-title":"Treatment patterns and use of resources in patients with tuberous sclerosis complex: insights from the TOSCA registry","volume":"10","author":"Marques","year":"2019","journal-title":"Front Neurol"},{"key":"B34","doi-asserted-by":"crossref","unstructured":"Patient Registries Workshop, 28 October 2016.","DOI":"10.1097\/01.ASW.0000466879.75073.11"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00365\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:08:35Z","timestamp":1589533715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00365\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":34,"alternative-id":["10.3389\/fneur.2020.00365"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00365","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]},"article-number":"365"}}